GTF2F2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.409400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.171800E-01
Normal-vs-Stage2
5.146200E-01
Normal-vs-Stage3
8.391600E-01
Normal-vs-Stage4
6.123400E-01
Stage1-vs-Stage2
7.219800E-01
Stage1-vs-Stage3
9.603200E-01
Stage1-vs-Stage4
9.999200E-01
Stage2-vs-Stage3
7.155800E-01
Stage2-vs-Stage4
7.685800E-01
Stage3-vs-Stage4
9.619600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.744200E-01
Normal-vs-AfricanAmerican
8.005800E-01
Normal-vs-Asian
2.816200E-01
Caucasian-vs-AfricanAmerican
6.265800E-01
Caucasian-vs-Asian
1.465970E-01
AfricanAmerican-vs-Asian
2.223400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.494800E-01
Normal-vs-Female
6.872000E-01
Male-vs-Female
1.050450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.210600E-01
Normal-vs-Age(41-60Yrs)
3.441800E-01
Normal-vs-Age(61-80Yrs)
6.691400E-01
Normal-vs-Age(81-100Yrs)
2.767400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.343000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.509600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.392000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.752600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.041400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.315360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.160400E-01
Normal-vs-Daily Drinker
6.424000E-01
Normal-vs-Weekly Drinker
5.131600E-01
Normal-vs-Occasional Drinker
2.015400E-01
Normal-vs-Social Drinker
5.110000E-01
Non Drinker-vs-Daily Drinker
9.757000E-01
Non Drinker-vs-Weekly Drinker
6.432200E-01
Non Drinker-vs-Occasional Drinker
1.422820E-01
Non Drinker-vs-Social Drinker
8.182200E-01
Daily Drinker-vs-Weekly Drinker
6.304200E-01
Daily Drinker-vs-Occasional Drinker
1.157190E-01
Daily Drinker-vs-Social Drinker
8.178200E-01
Weekly Drinker-vs-Occasional Drinker
3.773600E-01
Weekly Drinker-vs-Social Drinker
7.884400E-01
Occasional Drinker-vs-Social Drinker
1.925620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.240600E-01
Normal-vs-Grade 2
6.064600E-01
Normal-vs-Grade 3
1.149240E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.183800E-02
Grade 1-vs-Grade 3
2.976000E-02
Grade 1-vs-Grade 4
4.240600E-01
Grade 2-vs-Grade 3
6.906800E-01
Grade 2-vs-Grade 4
6.064600E-01
Grade 3-vs-Grade 4
1.149240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.929600E-01
Normal-vs-NonDiabetic
4.948000E-01
Diabetic-vs-NonDiabetic
8.242400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.726600E-01
Normal-vs-NoPancreatitis
5.399800E-01
Pancreatitis-vs-NoPancreatitis
4.400800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.020000E-01
Normal-vs-N1
5.626600E-01
N0-vs-N1
6.267000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.543210E-01
Normal-vs-TP53-NonMutant
8.606000E-01
TP53-Mutant-vs-TP53-NonMutant
4.20170000000608E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
